Abstract
HER2 is a driver in solid tumors, mainly breast, oesophageal and gastric cancer, through activation of oncogenic signaling pathways such as PI3K or MA......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
